KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Receivables (2016 - 2026)

Edwards Lifesciences has reported Receivables over the past 17 years, most recently at $912.1 million for Q4 2025.

  • For Q4 2025, Receivables rose 25.39% year-over-year to $912.1 million; the TTM value through Dec 2025 reached $912.1 million, up 25.39%, while the annual FY2025 figure was $912.1 million, 25.39% up from the prior year.
  • Receivables for Q4 2025 was $912.1 million at Edwards Lifesciences, up from $892.8 million in the prior quarter.
  • Over five years, Receivables peaked at $912.1 million in Q4 2025 and troughed at $661.4 million in Q3 2022.
  • A 5-year average of $767.8 million and a median of $765.6 million in 2023 define the central range for Receivables.
  • On a YoY basis, Receivables climbed as much as 25.39% in 2025 and fell as far as 14.25% in 2025.
  • Year by year, Receivables stood at $664.9 million in 2021, then grew by 5.14% to $699.1 million in 2022, then grew by 18.45% to $828.1 million in 2023, then decreased by 12.16% to $727.4 million in 2024, then grew by 25.39% to $912.1 million in 2025.
  • Business Quant data shows Receivables for EW at $912.1 million in Q4 2025, $892.8 million in Q3 2025, and $902.6 million in Q2 2025.